Urine test for ulcerative colitis activity
Part of Digestive system clinical trials.
This trial is testing a simple urine test that may show how active your ulcerative colitis is, using a substance called PGE-MUM. It could help doctors check your disease without needing a scope or other invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed diagnosis of ulcerative colitis (UC) with either active disease or remission.
- You do not have other types of colitis, like Crohn's disease.
- You have not had surgery to remove your colon.
- You are not a current smoker, and you do not have long-term lung or kidney disease, cancer, or an active infection.
- You agree not to use laxatives or NSAIDs (like ibuprofen) for 2 weeks before joining, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study looks at whether a special ultrasound test can better track how well a treatment called mirikizumab is working for people with moderate-to-severe ulcerative colitis. It may help doctors see if the treatment is reducing inflammation in the bowel more accurately than current methods.
This study tests whether monitoring ulcerative colitis with stool-based markers—simple, non-invasive tests—can help guide treatment as effectively as the usual care approach. It aims to see if this strategy helps you stay in remission and avoid flare-ups.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
This study tests an investigational pill for people with moderate-to-severe ulcerative colitis that has not improved with standard treatments. The goal is to see if the pill can reduce symptoms like bloody stools and frequent bowel movements.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.